-
IN RE SEBELA PATENT LITIGATION DC CAFC
- 2:14-cv-06414
- D.N.J.
- Judge: Claire C. Cecchi
+1
- Filed: 10/16/2014
- Closed: 09/14/2017
- Latest Docket Entry: 01/27/2022
- PACER
- Docket updated daily
2
Plaintiffs
4
Defendants
1
Accused
Product
3
Patents-in-Suit
1,065
Days in
Litigation
-
IN RE SEBELA PATENT LITIGATION DC CAFC
- 2:14-cv-06414
- D.N.J.
- Judge: Claire C. Cecchi
+1
- Filed: 10/16/2014
- Closed: 09/14/2017
- Latest Docket Entry: 01/27/2022
- PACER
- Docket updated daily
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
Crystalline paroxetine methanesulfonate having the following IR peaks: 531, 546, 777, 838, 931, 962, 1038, 1100, 1169, 1208, 1469, 1500, 1515, 1615, 2577, 2869, 2900, 3023.
|
Enforceable and Valid
Entry 308 |
| Claim | Outcome |
|---|---|
| All challenged claims |
Enforceable and Valid
Entry 336 |
| Claim # | Claim Text | Outcome |
|---|---|---|
| 1 |
A method for treating a patient suffering from a thermoregulatory dysfunction associated with menopause comprising administering paroxetine mesylate to said patient in an amount, based on the paroxetine moiety, of 7.5 mg/day.
|
Enforceable and Valid
Entry 308 |
| 2 |
The method of claim 1, wherein said thermoregulatory dysfunction is a condition selected from the group consisting of hot flashes, hot flushes, night sweats and combinations thereof.
|
Enforceable and Valid
Entry 308 |
| 5 |
A method for treating a patient suffering from a thermoregulatory dysfunction associated with menopause comprising administering paroxetine to said patient, wherein said paroxetine is in the form of a pharmaceutically acceptable mesylate salt, in
view more
|
Enforceable and Valid
Entry 308 |
-
Infringement
Actavis Laboratories FL Incorporated
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 7.5 mg generic paroxetine mesylate capsule | US 5,874,447 A | All Asserted Claims |
Infringement
Entry 336
|
| 7.5 mg generic paroxetine mesylate capsulegeneric paroxetine mesylate product | US 7,598,271 B1 |
1
|
Infringement
Entry 336Entry 308 |
| 7.5 mg generic paroxetine mesylate capsulegeneric paroxetine mesylate product | US 8,658,663 B2 |
1, 2, 5
|
Infringement
Entry 336Entry 308 |
-
Damages
